-
Neoangiogenesis and blood-brain barrier in L-DOPA-induced dyskinesia
… dyskinesia in the pre-clinical model. Objectives for Supplemental Investigation : In this project extension, we shall … with Dr. Paul Lockman (Texas Tech University of Health Sciences). In parallel, we shall examine the …
-
Michael J. Fox Foundation Vice President of Medical Communications Joins Alliance for Patient Access Meeting
July 29, 2016
… $600 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. … that support medical research and increased access to health care; and coordinates the involvement of thousands of …
-
Generating Patient-Specific Induced Pluripotent Stem Cells to Study Parkinson's Disease
… dopamine neurons in the brain of the original patients and healthy subjects. We will compare these human dopamine … Disorders and Stroke (NINDS) (National Institutes of Health) as part of the PD iPS Consortium to generate iPS …
-
Evaluation of Cortical Resonant Oscillations as a Novel Target for Treatment of Dyskinesia
… Parkinson’s disease (PD) by recording neuronal activity in healthy and in parkinsonian pre-clinical models. We recently … Hotel La Palma, Stresa, Italy “Basal ganglia circuits in health and disease” …
-
Regulation of Alpha-synucleinopathy by BPOZ-2
… is an important target for the restoration of neuronal health and function in PD. However, until now there is only …
-
Foundation Invites Parkinson's Organizations to Join in $4 Million "Community Fast Track 2003" Initiative
July 11, 2003
… MJFF, other private funders and the National Institutes of Health (NIH) in funding the “R21 Grants for Parkinson’s …